Search Results - O. N. Tkacheva

Refine Results
  1. 1
  2. 2

    Anticoagulant Therapy in “Fragile” Elderly Patients: Current State of the Problem by N. M. Vorobyeva, O. N. Tkacheva

    Published 2019-01-01

    The review focuses on the use of oral anticoagulants in fragile elderly patients. The issues of prevalence and diagnosis of senile asthenia syndrome or “fragility”, as well as its effects on the risks of thrombosis, bleeding and death, are discussed. The evidence base, which is quite limited, for th...

    Full description

    Get full text
    Article
  3. 3

    Vitamin D role in arterial hypertension development by E. N. Dudinskaya, O. N. Tkacheva

    Published 2012-06-01

    Recently obtained data have identified potential mechanisms linking D-endocrine system and blood pressure regulation. Vitamin D deficiency is associated with calcium metabolism disregulation, increased tonus of renin-angiotensin-aldosterone system, endothelial dysfunction, and metabolic syndrome dev...

    Full description

    Get full text
    Article
  4. 4

    DABIGATRAN ETEXILATE IN ELDERL Y PATIENTS WITH ATRIAL FIBRILLATION: WHATS NEW? by O. N. Tkacheva, N. M. Vorobyeva

    Published 2017-12-01

    The article discusses stroke prevention in elderly patients with atrial fibrillation. The principles of choosing anticoagulant therapy in this group of patients are discussed. The importance of the safety profile of the selected anticoagulant is emphasized considering the high prevalence of comorbid...

    Full description

    Get full text
    Article
  5. 5

    ADDITIONAL BENEFITS OF ANTIHYPERTENSIVE MOXONIDINE THERAPY IN POSTMENOPAUSAL WOMEN WITH ARTERIAL HYPERTENSION by E. N. Dudinskaya, O. N. Tkacheva

    Published 2014-02-01

    Aim. To assess the effects of moxonidine in terms of target blood pressure (BP) achievement; to identify potential additional benefits of moxonidine and its effects on bone metabolism and bone mineral density (BMD) in postmenopausal women with arterial hypertension (AH).Material and methods. The stu...

    Full description

    Get full text
    Article
  6. 6

    The phenomenon of intestinal permeability and its association with cardiovascular disease. Current status by D. A. Kashtanova, O. N. Tkacheva

    Published 2020-07-01

    Changes in the intestinal permeability in various pathologies are widely discussed in the scientific community. There is still no consensus on whether high intestinal permeability can lead to chronic noncommunicable diseases, but there is much evidence that increased permeability can aggravate some...

    Full description

    Get full text
    Article
  7. 7

    Value of Safety of Anticoagulant Therapy in Elderly Patient with Atrial Fibrillation and High Risk of Bleeding by N. M. Vorobyeva, O. N. Tkacheva

    Published 2023-03-01

    The review article discusses  the safety issue of anticoagulant therapy in elderly patients with atrial fibrillation and high risk of bleeding.  An evidence base is presented demonstrating the high safety of rivaroxaban in patients over 80  years of age,  with a high risk of bleeding  and cardiovasc...

    Full description

    Get full text
    Article
  8. 8

    The Oral Anticoagulants Administration in Elderly Patients with Geriatric Syndromes: What's New? by N. M. Vorobyeva, O. N. Tkacheva

    Published 2020-12-01

    The administration of oral anticoagulants in elderly patients with geriatric syndromes such as senile asthenia syndrome, falls and high risk of falls, dementia, polymorbidity, polypharmacy are discussed in the article. The evidence base for the anticoagulants taking in patients with atrial fibrillat...

    Full description

    Get full text
    Article
  9. 9

    Anti-platelet therapy algorithms in women by O. N. Tkacheva, T. V. Kirsanova, N. V. Latysheva

    Published 2011-02-01

    The review is focussed on the evidence base for anti-platelet therapy (APT) algorithms in women. Gender-specific features of haemostasis and thrombosis pathogenesis are emphasized. The “female” risk factors for thrombotic events include oral contraceptive use, pregnancy and post-labour period, menop...

    Full description

    Get full text
    Article
  10. 10

    GUT MICROBIOTA AND CARDIOVASCULAR RISK FACTORS. PART III. LIPID PROFILE, CARBOHYDRATE METABOLISM AND GUT MICROBIOTA by O. N. Tkacheva, D. A. Kashtanova, S. A. Boytsov

    Published 2015-12-01

    Of the main significantly prevalent modifiable risk factors of cardiovascular risk are carbohydrate and lipid metabolism disorders. Recent years have shown some findings of the mechanisms. The current review highlights contemporary understanding of the link of gut microbiota with carbohydrate and li...

    Full description

    Get full text
    Article
  11. 11

    GUT MICROBIOTA AND CARDIOVASCULAR RISK FACTORS. PART 2. GUT MICROBIOTA AND OBESITY by D. A. Kashtanova, O. N. Tkacheva, S. A. Boytsov

    Published 2015-10-01

    The importance of adipose tissue is much greater than it has been expected. Adipose tissue is a large endocrine organ, value of which is difficult to overestimate. Its work influences a lot of metabolic disorders, cardiovascular pathology. Recently, there is active research on the relation of obesit...

    Full description

    Get full text
    Article
  12. 12

    GUT MICROBIOTA AND CARDIOVASCULAR RISK FACTORS. PART 1. GUT MICROBIOTA, AGE AND SEX by D. A. Kashtanova, O. N. Tkacheva, S. A. Boytsov

    Published 2015-08-01

    The experience of the recent decade has led to ability of complex evaluation of human health, including not only external influences, genetic determinants, but to regard human body as an "environment" for billions of microbes that continuously interact with the host. Microbiota of the gut...

    Full description

    Get full text
    Article
  13. 13

    Gut microbiota and cardiovascular risk factors. Part IV. Arterial hypertension, smoking and the gut microbiota by D. A. Kashtanova, O. N. Tkacheva, S. A. Boytsov

    Published 2016-02-01

    The collected data on the interaction of human-as-host and their gut microbiota reveals new opportunities for further investigation and translation to practice the novel methods of the body influence in whole and on separate systems, particularly via correction of gut microbiota condition. Previous...

    Full description

    Get full text
    Article
  14. 14

    GUT ENTEROBIOTA — A NEW PLAYER IN ATHEROSCLEROSIS PATHOGENESIS by L. V. Egshatyan, O. N. Tkacheva, S. A. Boytsov

    Published 2014-12-01

    The article provides a review of contemporary literature, which generalizes experimental and clinical data on the role of gut microbiota in atherosclerosis development. Gut microflora can be named a marker of the macroorganism condition, reacting on age-related, physiological, dietic, climatogeoraph...

    Full description

    Get full text
    Article
  15. 15

    Nifedipine effects on blood cells and rheology in arterial hypertension and pregnancy by N. K. Runikhina, O. N. Tkacheva, B. Ya. Bart

    Published 2007-12-01

    Arterial hypertension (AH) in pregnancy is associated with systemic endothelial damage, vasoconstriction, and blood rheology disturbances, that results in microcirculation disorders, tissue and organ ischemia. Antihypertensive therapy effects on endothelium and blood cells in hypertensive pregnant w...

    Full description

    Get full text
    Article
  16. 16

    Chondropenia followed by epidemic of osteoarthritis: from joint aging to the clinical manifestations by A. V. Naumov, N. O. Hovasova, O. N. Tkacheva

    Published 2021-06-01

    Osteoarthritis (OA) is the most wide-spread and socially significant disease of musculoskeletal system. Systemic inflammation and formation of proinflammatory cytokines underlie OA, which, in its turn, conditions keeping pain syndrome and cartilage degradation. Currently, theory of chondropenia, due...

    Full description

    Get full text
    Article
  17. 17

    NEW ASPECTS OF MOXONIDINE USAGE IN FEMALE PATIENTS WITH ARTERIAL HYPERTENSION AND POSTMENOPAUSE by E. N. Dudinskaya, O. N. Tkacheva, I. D. Strajesko

    Published 2014-12-01

    The review of a new data is provided related to novel aspects of moxonidine use in the patients with arterial hypertension. The main attention is paid to the problem of vascular ageing, telomere biology, insulin resistance and calcium-phosphorum homeostasis. The possible ways to influence this proce...

    Full description

    Get full text
    Article
  18. 18

    MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION by E. A. Belikov, K. V. Davtyan, O. N. Tkacheva

    Published 2015-09-01

    Prevention of thromboembolic complications in patients with atrial fibrillation during catheter pulmonary veins isolation is discussed. This subject review is presented with special consideration to new anticoagulants.

    Get full text
    Article
  19. 19

    THE ROLE OF ACTIVATION OF THE SYMPATHETIC NERVOUS SYSTEM IN THE PATHOGENESIS OF ARTERIAL HYPERTENSION AND THE CHOICE OF A METHOD FOR THE TREATMENT OF ARTERIAL HYPERTENSION by A. V. Rozanov, Yu. V. Kotovskaya, O. N. Tkacheva

    Published 2018-09-01

    The basis for the successful treatment of any disease is a clear understanding of its cause, the mechanisms of its development, and their relationship to symptoms. The article considers one of the links in the pathogenesis of arterial hypertension - an increase in the activity of the sympathetic ner...

    Full description

    Get full text
    Article
  20. 20

    Calcium antagonist nifedipine in treating pregnant women with arterial hypertension: pro and contra by N. K. Runikhina, B. Ya. Bart, O. N. Tkacheva

    Published 2007-04-01

    Calcium antagonist nifedipine, an antihypertensive and anti-anginal medication with vasodilating action, is widely used in cardiology practice. According to the recommendations on cardiovascular disease management in pregnancy, by the European Society of Cardiology (2003) and Society of Cardiology o...

    Full description

    Get full text
    Article